MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2022-23)
- Udyam number
- UDYAM-DL-10-0016755
Genastro Pharmaceuticals Private Limited
Genastro Pharmaceuticals Private Limited - pharma in Delhi, India. Directors, charges & compliance details.
Revenue · FY 2025
₹8.78 Lakh
▲ 41% YoY
Net loss · FY 2025
₹11,031
Net margin -1.3%
EBITDA · FY 2025
-₹10,569
EBITDA margin -1.2%
Authorised capital
₹15 Lakh
Registered with MCA
Paid-up capital
₹5 Lakh
Issued & subscribed
Satisfied charges
₹18 Lakh
No open charges
Company age
5 yrs
Est. 2021
Directors on board
2
As per MCA filings
About Genastro Pharmaceuticals Private Limited
Data last updated:
Genastro Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 06 August 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24230DL2021PTC384887. Its GSTIN is 07AAJCG1917E1ZT (Delhi). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Arvind Kumar Dubey and Manish Kumar Dubey.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 308 Vardhman Sudershan Plaza Plot No 12 Sector 12 Dwarka, Delhi, India – 110078.
As per the financials filed for FY 2025, the company reported a revenue of ₹8.78 Lakh, a growth of 41% compared to the previous year. For the same year it recorded a net loss of ₹11,031 (net margin -1.3%) and EBITDA of -₹10,569 (EBITDA margin -1.2%). Revenue has grown at a compounded annual rate (CAGR) of 130% over three years.
As per MCA filings, the company has satisfied charges of ₹18 Lakh on record.
Genastro Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-10-0016755).
Company details
CIN U24230DL2021PTC384887
Registration Number 384887
Incorporation Date 06 August 2021
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-DL-10-0016755
Recognitions & Rankings of Genastro Pharmaceuticals
Contact details
Genastro Pharmaceuticals Private Limited's registered office is in Delhi, Delhi.
- Registered Address308 Vardhman Sudershan Plaza Plot No 12 Sector 12 Dwarka, Delhi, India – 110078
- IndustryPharma, Drug Formulation & Development
Comprehensive company report
Genastro Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Genastro Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Genastro Pharmaceuticals Private Limited, buy the company report.
Financials of Genastro Pharmaceuticals Private Limited
FY 2025 filings availableGenastro Pharmaceuticals Private Limited reported revenue of ₹8.78 Lakh (up 41% YoY) for FY 2025.
Revenue · FY 2025
₹8.78 Lakh ▲ 41%
Net loss · FY 2025
₹11,031 margin -1.3%
EBITDA · FY 2025
-₹10,569 margin -1.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 41%
3 years · compounded
▲ 130%
EBITDA CAGR growth
1 year
▲ 3%
3 years · compounded
▲ 44%
Revenue has grown at a compounded annual rate (CAGR) of 130% over three years, including 41% growth in the latest year. EBITDA rose 3% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹10,569 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹11,031 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -1.2% | |||
| Net Profit Margin | -1.3% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Genastro Pharmaceuticals Private Limited, buy the company report.
Board of directors of Genastro Pharmaceuticals Private Limited
Genastro Pharmaceuticals has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Arvind Kumar Dubey | Director | 06 Aug 2021 | 5 Years 3 Months | Current |
| Manish Kumar Dubey | Director | 06 Aug 2021 | 5 Years 3 Months | Current |
Peer comparison
Genastro Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Medicostar Pharmaceuticals Private Limited | ₹8.88 Lakh (FY 2024) | 108.0% | Surat, Gujarat, India | |||
| Ulcone Pharmaceuticals Private Limited | ₹8.79 Lakh (FY 2025) | 379.0% | Patna, Bihar, India | |||
| Genastro Pharmaceuticals Private Limitedthis company | ₹8.78 Lakh (FY 2025) | -₹11,031 | -1.3% | 41.0% | Delhi, India | |
| Ealder Pharmaceuticals Private Limited | ₹8.78 Lakh (FY 2023) | 21.0% | Ashiana Nagar, Bihar, India | |||
| Groove Pharmaceuticals Private Limited | ₹8.75 Lakh (FY 2024) | -27.0% | Mandir, Chembur (W), Maharashtra, India | |||
| Nordisk Pharmaceuticals Private Limited | ₹8.73 Lakh (FY 2023) | 16.0% | Rewa, Madhya Pradesh, India |
To see the full peer comparison of Genastro Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
None
Satisfied charges
₹18 Lakh
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 24 Feb 2022 | 100548949 | Others | ₹18 Lakh | Satisfied |
To see the full charge records of Genastro Pharmaceuticals Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Genastro Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Genastro Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Genastro Pharmaceuticals has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAJCG1917E1ZT | Delhi | Active | 09 Sep 2021 |
| 09AAJCG1917E1ZP | Uttar Pradesh | Active | 09 Nov 2021 |
To see the full GST registrations and return filing status of Genastro Pharmaceuticals Private Limited, buy the company report.
Recent activity
Genastro Pharmaceuticals Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Arvind Kumar Dubey was appointed as Director on 06 Aug 2021.
AGM
Genastro Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Genastro Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi I.
Charges
A charge registered on 24 Feb 2022 via Charge ID 100548949 with Others was fully satisfied on 30 May 2024.
Charges
A charge with Others amounted to Rs. 18.00 Lakh with Charge ID 100548949 was registered on 24 Feb 2022.
Appointed
Arvind Kumar Dubey was appointed as Director.
Appointed
Manish Kumar Dubey was appointed as Director.
Incorporation
06 Aug 2021
Genastro Pharmaceuticals Private Limited was registered on 06 Aug 2021 with Roc Delhi I & aged 5 years 3 months as per MCA records.
Frequently asked questions
Genastro Pharmaceuticals is an active private limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 06 August 2021 (5+ years old) and is registered under CIN U24230DL2021PTC384887.
Genastro Pharmaceuticals has 2 current directors:
- Arvind Kumar Dubey - Director
- Manish Kumar Dubey - Director
The latest financial statements of Genastro Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Genastro Pharmaceuticals is 07AAJCG1917E1ZT, registered in Delhi. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 09AAJCG1917E1ZP (Uttar Pradesh).
The CIN (Corporate Identification Number) of Genastro Pharmaceuticals is U24230DL2021PTC384887. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Genastro Pharmaceuticals was incorporated on 06 August 2021, making it 5+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Genastro Pharmaceuticals by revenue are Medicostar Pharmaceuticals Private Limited, Ulcone Pharmaceuticals Private Limited, Ealder Pharmaceuticals Private Limited, Groove Pharmaceuticals Private Limited, Nordisk Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Arvind Kumar Dubey was appointed as Director on 06 Aug 2021. Manish Kumar Dubey was appointed as Director on 06 Aug 2021.
Yes, Genastro Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-10-0016755).
The registered office of Genastro Pharmaceuticals is at 308 Vardhman Sudershan Plaza Plot No 12 Sector 12 Dwarka, Delhi, India – 110078.
Genastro Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages